論文

査読有り 国際誌
2017年4月18日

Parathyroid hormone controls paracellular Ca2+ transport in the thick ascending limb by regulating the tight-junction protein Claudin14.

Proceedings of the National Academy of Sciences of the United States of America
  • Tadatoshi Sato
  • Marie Courbebaisse
  • Noriko Ide
  • Yi Fan
  • Jun-Ichi Hanai
  • Jovana Kaludjerovic
  • Michael J Densmore
  • Quan Yuan
  • Hakan R Toka
  • Martin R Pollak
  • Jianghui Hou
  • Beate Lanske
  • 全て表示

114
16
開始ページ
E3344-E3353
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1073/pnas.1616733114

Renal Ca2+ reabsorption is essential for maintaining systemic Ca2+ homeostasis and is tightly regulated through the parathyroid hormone (PTH)/PTHrP receptor (PTH1R) signaling pathway. We investigated the role of PTH1R in the kidney by generating a mouse model with targeted deletion of PTH1R in the thick ascending limb of Henle (TAL) and in distal convoluted tubules (DCTs): Ksp-cre;Pth1r
fl/fl
Mutant mice exhibited hypercalciuria and had lower serum calcium and markedly increased serum PTH levels. Unexpectedly, proteins involved in transcellular Ca2+ reabsorption in DCTs were not decreased. However, claudin14 (Cldn14), an inhibitory factor of the paracellular Ca2+ transport in the TAL, was significantly increased. Analyses by flow cytometry as well as the use of Cldn14-lacZ knock-in reporter mice confirmed increased Cldn14 expression and promoter activity in the TAL of Ksp-cre;Pth1r
fl/fl
mice. Moreover, PTH treatment of HEK293 cells stably transfected with CLDN14-GFP, together with PTH1R, induced cytosolic translocation of CLDN14 from the tight junction. Furthermore, mice with high serum PTH levels, regardless of high or low serum calcium, demonstrated that PTH/PTH1R signaling exerts a suppressive effect on Cldn14. We therefore conclude that PTH1R signaling directly and indirectly regulates the paracellular Ca2+ transport pathway by modulating Cldn14 expression in the TAL. Finally, systemic deletion of Cldn14 completely rescued the hypercalciuric and lower serum calcium phenotype in Ksp-cre;Pth1r
fl/fl
mice, emphasizing the importance of PTH in inhibiting Cldn14. Consequently, suppressing CLDN14 could provide a potential treatment to correct urinary Ca2+ loss, particularly in patients with hypoparathyroidism.

リンク情報
DOI
https://doi.org/10.1073/pnas.1616733114
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28373577
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402431
ID情報
  • DOI : 10.1073/pnas.1616733114
  • PubMed ID : 28373577
  • PubMed Central 記事ID : PMC5402431

エクスポート
BibTeX RIS